4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Advanced Biomed Inc. (ADVB) operates in the Diagnostics & Research industry and is headquartered in New York, United States with about 31 employees. Its market capitalization is roughly $28 million.
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan.
Interactive charts & full statements →
| Income statement | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Revenue | — | $0M | $0M | $0M |
| Operating Income (EBIT) | — | ($2M) | ($3M) | ($2M) |
| Net Income | — | ($3M) | ($4M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($0M) | ($0M) | ($0M) | ($1M) | ($0M) |
| Net Income | ($0M) | $7M | ($0M) | ($1M) | ($1M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Total Assets | — | $4M | $5M | $7M |
| Total Liabilities | — | $3M | $3M | $3M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ADVB viewer.
About TickerBase · Data methodology & sources